1159815-52-7Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
-
Paragraph 0410; 0412, (2020/08/05)
Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in onco
Substituted pyrazine compound as well as preparation method and application thereof
-
Paragraph 0249; 0250; 0251-0253, (2020/07/24)
The invention discloses a substituted pyrazine compound as an adenosine receptor antagonist, a preparation method and an intermediate thereof, a pharmaceutical composition containing the substituted pyrazine compound, and a therapeutic application of the
PIPERIDINYLALKYLAMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
-
Page/Page column 113-114, (2017/11/10)
The present invention relates to piperidinylalkylamide derivatives having dual pharmacological activity towards both the sigma (σ) receptor and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising